Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer

Published:2021-12 Issue:6 Volume:160 Page:2293-2303
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Fox Adam H.,Jett James R.,Roy Upal Basu,Johnson Bruce E.,King Jennifer C.,Martin Nikki,Osarogiagbon Raymond U.,Rivera M. Patricia,Rosenthal Lauren S.,Smith Robert A.,Silvestri Gerard A.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference42 articles.

1. The effect of advances in lung-cancer treatment on population mortality;Howlader;N Engl J Med,2020

2. Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer;Schiller;N Engl J Med,2002

3. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study;Mok;Ann Oncol,2020

4. Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs;Lin;J Thorac Oncol,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker Testing for Guiding Precision Medicine for Patients with Non-Small Cell Lung Cancer;CHEST;2024-08

2. Health Care Provider Practices and Perceptions of Biomarker Testing in US Veterans With Non-Small Cell Lung Cancer;CHEST;2024-08

3. Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022;Cancer Epidemiology, Biomarkers & Prevention;2024-06-17

4. Knowledge, Attitudes, and Practices of Physicians Regarding Targeted Drug Therapy for Lung Cancer;International Journal of General Medicine;2024-06

5. Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries;The Lancet Regional Health - Europe;2024-03